Business Wire25d
Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
--(BUSINESS WIRE)--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound ... The silver/gallium matrix addresses the unmet need for a lightweight, shelf-stable and easy-to-use ...
Morningstar25d
Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
Morningstar brands and products Company Portfolio ...
Yahoo Finance25d
Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
are inevitably contaminated with bacteria that may colonize and form biofilm that impair wound healing. The silver/gallium matrix addresses the unmet need for a lightweight, shelf-stable and ...